Bristol Gate Capital Partners Inc. Has $88.18 Million Stake in Zoetis Inc. (NYSE:ZTS)

Key Points

• Bristol Gate Capital Partners Inc. increased its stake in Zoetis Inc. by 1.5% during the first quarter, acquiring an additional 7,804 shares, bringing their total holdings to 535,584 shares.
• Multiple analysts have varying opinions on Zoetis, with Piper Sandler raising the price target to $210.00 and UBS Group lowering theirs to $170.00, reflecting a mix of confidence and caution in the stock.
• Zoetis declared a quarterly dividend of $0.50, which will be paid on September 3rd, representing an annualized dividend yield of 1.32% and a payout ratio of 35.91%.

Bristol Gate Capital Partners Inc. lifted its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 1.5% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 535,584 shares of the company's stock after buying an additional 7,804 shares during the period. Zoetis makes up 4.3% of Bristol Gate Capital Partners Inc.'s holdings, making the stock its 14th largest position. Bristol Gate Capital Partners Inc. owned about 0.12% of Zoetis worth $88,184,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Navigoe LLC bought a new stake in shares of Zoetis in the 4th quarter worth $30,000. Cornerstone Planning Group LLC raised its position in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock worth $30,000 after purchasing an additional 88 shares during the period. Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Zoetis by 87.6% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 257 shares of the company's stock worth $42,000 after purchasing an additional 120 shares during the period. Sound Income Strategies LLC raised its position in shares of Zoetis by 141.4% during the first quarter. Sound Income Strategies LLC now owns 280 shares of the company's stock worth $46,000 after purchasing an additional 164 shares during the period. Finally, Bfsg LLC raised its position in Zoetis by 614.6% during the first quarter. Bfsg LLC now owns 293 shares of the company's stock valued at $48,000 after buying an additional 252 shares during the period. Institutional investors own 92.80% of the company's stock.

Zoetis Stock Up 1.1%

ZTS stock traded up $1.61 during mid-day trading on Friday, hitting $147.40. The stock had a trading volume of 3,145,842 shares, compared to its average volume of 3,061,625. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12. Zoetis Inc. has a 1-year low of $139.70 and a 1-year high of $200.33. The company has a fifty day moving average of $158.82 and a 200 day moving average of $160.58. The stock has a market capitalization of $65.62 billion, a price-to-earnings ratio of 26.46, a PEG ratio of 2.47 and a beta of 0.91.

Zoetis (NYSE:ZTS - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The company had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same period in the prior year, the firm posted $1.38 EPS. The business's revenue was up 1.4% compared to the same quarter last year. On average, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. Zoetis's dividend payout ratio is currently 35.91%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the company. Leerink Partners lowered Zoetis from an "outperform" rating to a "market perform" rating and dropped their price target for the company from $180.00 to $155.00 in a research report on Thursday, July 17th. Stifel Nicolaus lowered Zoetis from a "buy" rating to a "hold" rating and dropped their price target for the company from $165.00 to $160.00 in a research report on Wednesday, June 18th. Piper Sandler upped their price target on Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a research report on Monday, May 12th. UBS Group dropped their price target on Zoetis from $189.00 to $170.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. Finally, Leerink Partnrs lowered Zoetis from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. Four investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Zoetis has a consensus rating of "Moderate Buy" and a consensus target price of $204.63.

Insider Activity at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total transaction of $110,840.00. Following the transaction, the executive vice president owned 15,129 shares of the company's stock, valued at approximately $2,571,930. This represents a 4.13% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.18% of the company's stock.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.